Gemma Moir-Meyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gemma Moir-Meyer has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Alexandra L. Garnham
Walter and Eliza Hall Institute of Medical Research
1 shared publication- Ali Shokoohmand
School of Chemical Engineering, The University of Queensland, Brisbane, Queensland, Australia; Translational Research Institute (TRI), The University of Queensland, Brisbane, Queensland, Australia
1 shared publication - Alicia J. Didsbury
School of Biological Sciences, Faculty of Science, University of Auckland, Auckland, New Zealand
1 shared publication Anna Koptina
1 shared publicationAnne Pettikiriarachchi
Walter and Eliza Hall Institute of Medical Research
1 shared publication- Arwa Z. Al-Riyami
Department of Hematology Sultan Qaboos University Hospital, University Medical City Muscat Oman
1 shared publication
Latest Publications
- Open Access
Regulation of Human Erythroferrone Expression
Erythroferrone (ERFE) is an erythroblast-secreted hormone that suppresses hepatic hepcidin expression to increase iron availability for erythropoiesis, ensuring recovery from anaemia. ERFE excess drives iron overload in disorders of ineffective erythropoiesis. Despite its pivotal role in systemic iron homeostasis and diseases of erythropoiesis, ERFE 's molecular regulation has remained undefined. Here, we applied a genomic approach to characterise the molecular mechanisms governing ERFE expression. Using the HUDEP-2 human erythroid progenitor model, integrative ATAC-seq, CUT&RUN and micro capture-C analysis we identified a stage-specific accessible chromatin region within the ERFE 3' UTR that interacts with the promotor. We also identified enhancer-associated chromatin marks including H3K4me1 and H3K27ac in this region, and demonstrate that this cis -regulatory element is bound by key erythroid transcription factors KLF1, GATA1, TAL1 and STAT5. Functional dissection using CRISPR-Cas9-mediated deletion of the central 3' UTR enhancer element led to marked reduction in ERFE mRNA expression, and we show a corresponding reduction in nascent mRNA, confirming a key role for this region in transcriptional regulation. We define the transcriptional regulatory mechanism by which maturing human erythroblasts activate ERFE , the endocrine signal that coordinates erythropoietic demand with systemic iron mobilisation.
Open AccessRegulation of Human Erythroferrone Expression
Erythroferrone (ERFE) is an erythroblast-secreted hormone that suppresses hepatic hepcidin expression to increase iron availability for erythropoiesis, ensuring recovery from anaemia. ERFE excess drives iron overload in disorders of ineffective erythropoiesis. Despite its pivotal role in systemic iron homeostasis and diseases of erythropoiesis, ERFE 's molecular regulation has remained undefined. Here, we applied a genomic approach to characterise the molecular mechanisms governing ERFE expression. Using the HUDEP-2 human erythroid progenitor model, integrative ATAC-seq, CUT&RUN and micro capture-C analysis we identified a stage-specific accessible chromatin region within the ERFE 3' UTR that interacts with the promotor. We also identified enhancer-associated chromatin marks including H3K4me1 and H3K27ac in this region, and demonstrate that this cis -regulatory element is bound by key erythroid transcription factors KLF1, GATA1, TAL1 and STAT5. Functional dissection using CRISPR-Cas9-mediated deletion of the central 3' UTR enhancer element led to marked reduction in ERFE mRNA expression, and we show a corresponding reduction in nascent mRNA, confirming a key role for this region in transcriptional regulation. We define the transcriptional regulatory mechanism by which maturing human erythroblasts activate ERFE , the endocrine signal that coordinates erythropoietic demand with systemic iron mobilisation.
- Open Access
- 26 April 2026
- Published by Elsevier in Cytotherapy
- Vol. 28 (11)
From Classroom to Cleanroom: Building a Skilled Cell and Gene Therapy Workforce
- 26 April 2026
- Published by Elsevier in Cytotherapy
- Vol. 28 (11)
Open AccessFrom Classroom to Cleanroom: Building a Skilled Cell and Gene Therapy Workforce